PRESS RELEASE
13 June 2024

What’s New In Digital Therapeutics? Investment Strategies, Reimbursement, And More From DTA Annual Summit Day 1

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Medtech Insight covered significant takeaways from the Digital Therapeutics Alliance Annual Summit, highlighting Member Daniel Cody’s perspective of the challenges...
United States

Medtech Insight covered significant takeaways from the Digital Therapeutics Alliance Annual Summit, highlighting Member Daniel Cody's perspective of the challenges posed by payer-driver demands for digital therapeutics to be treated like prescription drugs.

Dan said, "We've gotten to this place because of payers. Payers really wanted these products to be prescription drugs. That was the only way they could comprehend it. At the end of the day, we need a separate benefit category, but that's going to take time."

SOURCE

Medtech Insight

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More